Erken dönemde ölüm ile sonuçlanan beyin ve kemik metastazı mevcut endometrioid tip endometrium adenokanseri: vaka sunumu

Year 2017, Volume: 20 Issue: 3, 26 - 28, 04.08.2019

Fatih Aktoz , Ali Can Güneş Onur Can Zaim Mehmet Coşkun Salman

Abstract

Endometriyal kanser gelişmiş ülkelerde en sık görülen jinekolojik
kanserdir. Beyin ve kemik metastazı oldukça nadir görülmektedir. 47 yaşında,
gravida 1, parite 1 kadın hasta menometroraji sebebiyle yapılan endometriyal
biyopside grade 2 endometriod tip endometrium kanseri tanısı almıştır.
Hastanemize sevk edilmiş ve hastanemizde opere edilmiştir. Bir ay sonra,
parestezi şikayeti ile acil servise başvuan hastanın beyin MR’ında çok sayıda
metastatik lezyon tespit edilmiştir. Beyin radyoterapisinin tamamlanmasından
sonra hastanın medical durumu kötüleşmiştir. Dispne ve kemik ağrıları
şikayetleri olması üzerine toraks görüntülemesi yapılmıştır. Metastatik kemik
ve akciğer lezyonları tespit edilmiştir. Hasta postoperatif 76.günde hayatını
kaybetmiştir. Bildiğimiz kadarıyla bu vaka, kemik ve beyin metastazı ile
seyreden literatürdeki altıncı vakadır. 

Keywords

endometriyal kanser, beyin metastazı, kemik metastazı

Endometrioid type endometrium adenocarcinoma with brain and bone metastasis with early fatal outcome: a case report

Abstract

Endometrial cancer is the most common gynaecological
cancer in developed countries and brain and bone metastasis are extremely rare.
A 47-year-old, gravida 1, parity 1 woman had been diagnosed to have grade 2,
endometrioid type carcinoma of the endometrium by an endometrial biopsy done
for a complaint of menometrorrhagia. She was referred and operated in our
hospital. One month later, she admitted to the emergency department of our
hospital with paresthaesia on the right side and multiple metastatic lesions
were detected in her brain MRI. After the completion of the brain radiotherapy,
her medical condition were deteriorated. She had complaints of dyspnea and bone
pains. Imaging of the thorax showed multiple metastatic lesions in bones and
lungs. The patient was died on the 76th postoperative day. To our knowledge,
this patient was the sixth case of the endometrial cancer with concomitant bone
and brain metastases.

Keywords

endometrial cancer, brain metastasis, bone metastasis

References

• Referans1 Doger E, Cakiroglu Y, Ozdamar O, Ceylan Y, Kole E, Yucesoy I, et al. Bone metastasis in endometrial cancer: evaluation of treatment approaches by factors affecting prognosis. Eur J Gynaecol Oncol. 2016;37(3):407-16.
• Referans2 Uccella S, Morris JM, Multinu F, Cliby WA, Podratz KC, Gostout BS, et al. Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature. Gynecol Oncol. 2016;142(1):70-5.
• Referans3 Loizzi V, Cormio G, Cuccovillo A, Fattizzi N, Selvaggi L. Two cases of endometrial cancer diagnosis associated with bone metastasis. Gynecol Obstet Invest. 2006;61(1):49-52.
• Referans4 Shigemitsu A, Furukawa N, Koike N, Kobayashi H. Endometrial cancer diagnosed by the presence of bone metastasis and treated with zoledronic Acid: a case report and review of the literature. Case Rep Oncol. 2010;3(3):471-6.
• Referans5 Croucher P, Jagdev S, Coleman R. The anti-tumor potential of zoledronic acid. Breast. 2003;12 Suppl 2:S30-6.
• Referans6 Piura E, Piura B. Brain metastases from endometrial carcinoma. ISRN Oncol. 2012;2012:581749.